Purchase Order 75N91024P00073
Award Date
12/1/23
Potential Completion Date
12/7/24
Potential Value
$20K
Federal Agency
National Cancer Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $15,388.08 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for a service agreement for a MiSeq M05802 sequencing system, with a completion date of December 7, 2025. Illumina has previously received prime contracts and subcontracts from various federal agencies, including the NIH, CDC, USDA, and VA, to provide sequencing...
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $24,230.96 contract provides Illumina sequencing systems, reagents, and services to support genomic research and diagnostics. The award is not associated with a set-aside program. Through past prime contract and subcontract awards, Illumina has...
This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for $80,547.47 to provide Illumina reagent kits. The award has a ceiling value of $81,551.80 and an ultimate completion date of September 30, 2024. This purchase order was issued under a Special Notice solicitation that was not set aside for any specific business category. Illumina is a...
This is a $16,198 firm fixed price purchase order awarded by the National Cancer Institute to Illumina, Inc. for a service agreement to provide their MiSeq next-generation sequencing instrument. The contract has no set-aside designation and runs through July 31, 2025. Illumina is a manufacturer of genomic sequencing and analysis instruments and has previously been awarded prime contracts and subcontracts by the National Institutes of Health (NIH), Centers for Disease Control and Prevention...
This is a firm fixed price delivery order awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $26,800.70 award is for the provision of biological kits, Illumina sequencing equipment, and associated services. Illumina has been a frequent supplier of sequencing technology and expertise to federal agencies like the NIH, CDC, USDA, and VA. This award does not utilize any set-aside...
This is a firm fixed price delivery order awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to Illumina, Inc. for $35,017.88. The award does not have a set-aside designation. Illumina is a manufacturer and provider of genetic sequencing and analysis instruments and reagents. Under this order, Illumina is providing various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and related products and services to support genomic...
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of sequencing and array-based genomics analysis solutions. The contract, valued at $62,099.44, is for the provision of sequencing kits, reagents, and other consumables to support Illumina sequencing platforms such as NextSeq, NovaSeq, MiSeq, and iSeq. This award is not associated with any set-aside...
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of biological kits. The order has a ceiling value of $45,077.60 and a period of performance through April 30, 2025. Illumina, a manufacturer of sequencing and genomic analysis products, has previously received prime federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA to...
This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency of the U.S. government, to Illumina, Inc. for $98,250.35. The award is not associated with a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, will provide a range of goods and services to support genomic sequencing and analysis, including various NextSeq, NovaSeq, MiSeq, and...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...